Abbie Celniker

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 31% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Carisma Therapeutics Inc Sept. 20, 2016 - Aug. 7, 2018
President, Chief Executive Officer, Director Carisma Therapeutics Inc Sept. 1, 2011 - Sept. 20, 2016
Independent Director Dyax Corp May 12, 2015 - Jan. 22, 2016
Abbie Celniker's trades of Carisma Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2016-09-30 2016-09-28
S Sale
75,129 +46.3%
54.17
US$761,188 		75,129 +46.3% 54.17 US$761,188